The Column Group
San Francisco, USA · Growth → Series C+
Their stated focus (public profile)
The Column Group (TCG) is a life sciences venture ecosystem focused on fueling scientific innovation in biotechnology through an edge-to-edge investment model. TCG deploys capital across an ecosystem of funds (Platform, Opportunity, Labs-Soleil, and Crossover) spanning early company formation through later-stage and public market support. The firm emphasizes hands-on company building, deep scientific rigor, and partnering with founders from inception through exit to achieve therapeutic breakthroughs.
Stages: Growth → Series C+
Sectors: Life sciences, Epigenetics
On file: 9 partners on record · 30 companies on record
Website: thecolumngroup.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.